<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
<journal-title-group>
<journal-title>medRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">medRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/2020.12.10.20247361</article-id>
<article-version>1.2</article-version>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Epidemiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>COVID-19 PREDICTION IN SOUTH AFRICA: ESTIMATING THE UNASCERTAINED CASES- THE HIDDEN PART OF THE EPIDEMIOLOGICAL ICEBERG</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Gu</surname><given-names>Xuelin</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mukherjee</surname><given-names>Bhramar</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Das</surname><given-names>Sonali</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5991-5182</contrib-id>
<name><surname>Datta</surname><given-names>Jyotishka</given-names></name>
<xref ref-type="aff" rid="a4">4</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Biostatistics, University of Michigan, Ann Arbor</institution>, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Department of Biostatistics, Department of Epidemiology, University of Michigan</institution>, Ann Arbor, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Department of Business Management, University of Pretoria, Pretoria</institution>, <country>South Africa</country></aff>
<aff id="a4"><label>4</label><institution>Department of Statistics, Virginia Polytechnic Institute and State University</institution>, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Email: <email>jyotishka@vt.edu</email></corresp>
<fn id="n1" fn-type="other"><p>Email: <email>xuelingu@umich.edu</email>, Email: <email>bhramar@umich.edu</email>, Email: <email>sonali.das@up.ac.za</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<year>2021</year>
</pub-date>
<elocation-id>2020.12.10.20247361</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>12</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>2</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>3</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/">http://creativecommons.org/licenses/by-nd/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="20247361.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>SUMMARY</title>
<p>Understanding the impact of non-pharmaceutical interventions as well as accounting for the unascertained cases remain critical challenges for epidemiological models for understanding the transmission dynamics of COVID-19 spread. In this paper, we propose a new epidemiological model (eSEIRD) that extends the widely used epidemiological models such as extended Susceptible-Infected-Removed model (eSIR) and SAPHIRE (initially developed and used for analyzing data from Wuhan). We fit these models to the daily ascertained infected (and removed) cases from March 15, 2020 to Dec 31, 2020 in South Africa that reported the largest number of confirmed COVID-19 cases and deaths from the WHO African region. Using the eSEIRD model, the COVID-19 transmission dynamics in South Africa was characterized by the estimated basic reproduction number (<italic>R</italic><sub>0</sub>) starting at 3.22 (95%CrI: [3.19, 3.23]) then dropping below 2 following a mandatory lockdown implementation and subsequently increasing to 3.27 (95%CrI: [3.27, 3.27]) by the end of 2020. The initial decrease of effective reproduction number followed by an increase suggest the effectiveness of early interventions and the combined effect of relaxing strict interventions and emergence of a new coronavirus variant in South Africa. The low estimated ascertainment rate was found to vary from 1.65% to 9.17% across models and time periods. The overall infection fatality ratio (IFR) was estimated as 0.06% (95%CrI: [0.04%, 0.22%]) accounting for unascertained cases and deaths while the reported case fatality ratio was 2.88% (95% CrI: [2.45%, 6.01%]). The models predict that from December 31, 2020, to April 1, 2021, the predicted cumulative number of infected would reach roughly 70% of total population in South Africa. Besides providing insights on the COVID-19 dynamics in South Africa, we develop powerful forecasting tools that enable estimation of ascertainment rates and IFR while quantifying the effect of intervention measures on COVID-19 spread.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords and phrases</title>
<kwd>COVID-19</kwd>
<kwd>South Africa</kwd>
<kwd>forecasting</kwd>
<kwd>unascertained cases</kwd>
<kwd>underreporting factors</kwd>
<kwd>infection fatality ratio</kwd>
</kwd-group>
<counts>
<page-count count="25"/>
</counts>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<notes notes-type="financial-disclosure">
<title>Funding Statement</title><p>This work was supported by grants from the National Science Foundation [grant numbers DMS- 1712933 (to B.M.) and DMS-2015460 (to J.D.)] and from National Institute of Health [grant number 1 R01 HG008773-01 (to B.M.)]. The first and second author (X.G. and B.M.) would also like to thank the Center for Precision Health Data Sciences at the University of Michigan School of Public Health, The University of Michigan Rogel Cancer Center and the Michigan Institute of Data Science for internal funding that supported this research.
</p></notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>No IRB was needed.</p><p>All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p>Yes</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Results section updated based on models fit to data from March 15, 2020 to Dec 31, 2020, and predicted from Jan 1, 2021 to March 9, 2021. Revised the methods section to include more details on the hierarchical models used and proposed.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<label>1</label>
<title>Introduction</title>
<p>The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in early December 2019 in Wuhan, China and then quickly spread to majority countries worldwide. At the end of January 2021, over a hundred million people worldwide have been diagnosed with COVID-19 [<xref ref-type="bibr" rid="c30">30</xref>], yet the true number of infections in the population remains underestimated, owing to a combination of selection bias from unascertained cases and lack of access to tests early on during the pandemic.</p>
<sec id="s1a">
<title>South Africa</title>
<p>Consider the transmission dynamics we have observed so far in South Africa, the &#x2018;epicenter of the outbreak in the African continent&#x2019; [<xref ref-type="bibr" rid="c29">29</xref>]. The first case was confirmed in South Africa on March 5, 2020. As of February 23, 2021, there are 1,504,588 confirmed cases of COVID-19 (cumulative total) with 49,150 deaths confirmed in Africa [<xref ref-type="bibr" rid="c30">30</xref>]. South Africa remains the worst-hit African country with the largest number of confirmed cases and deaths, by the end of 2020, contributing to 54% of the total confirmed cases and 44% of deaths in the WHO African region, while accounting for only 5% of population [<xref ref-type="bibr" rid="c26">26</xref>]. A seroprevalence survey on 4,858 blood donors in South Africa estimated the prevalence of mid January 2021 by province as 63% in the Eastern Cape, 52% in the KwaZulu Natal, 46% in the Free State and 32% in the Northern Cape [<xref ref-type="bibr" rid="c38">38</xref>] while the the number of reported cases is 1.83% of the total population at the same time, implying the possibility of a large degree of under-reporting/undetected cases in South Africa. Thus, understanding the key epidemiological constructs for COVID-19 outbreak is paramount for containing the spread of COVID-19 in South Africa, as well as explaining the disparity between seroprevalence estimates and reported number of cases. Two critical factors emerge from analyzing the majority of available evidence of the public health crisis: (1) the unascertained cases and deaths and (2) the role of non-pharmaceutical interventions.</p>
</sec>
<sec id="s1b">
<title>Unascertained cases and deaths</title>
<p>Based on the clinical characteristics of COVID-19, a majority of patients are symptomatic (roughly 84% according to a recent study [<xref ref-type="bibr" rid="c16">16</xref>]), most of whom have mild symptoms [<xref ref-type="bibr" rid="c29">29</xref>] and tend to not seek testing and medical care. While private hospitals have reached maximum capacity, public and field hospitals beds have still some margin left with additional challenges due to scarcity of staff [<xref ref-type="bibr" rid="c9">9</xref>]. Several recent studies [<xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c32">32</xref>, <xref ref-type="bibr" rid="c4">4</xref>] reported that a non-negligible proportion of unascertained cases contributed to the quick spreading of COVID-19. It is suggested that only 1 in 4 mildly ill cases would be detected in South Africa [<xref ref-type="bibr" rid="c8">8</xref>]. The relatively lower testing rate in South Africa (<xref rid="tbl1" ref-type="table">Table 1</xref>; <xref rid="fig1" ref-type="fig">Figure 1</xref>) coupled with a very high test positivity rate especially in July and August [<xref ref-type="bibr" rid="c18">18</xref>], suggests inadequacy of testing, as well as the possibility of a large unobserved number of unascertained cases [<xref ref-type="bibr" rid="c27">27</xref>]. Thus, modeling both ascertained and unascertained cases and deaths can measure infection fatality ratios (IFRs, the proportion of deaths among all infected individuals [<xref ref-type="bibr" rid="c28">28</xref>]) of COVID-19, leading to a better understanding of the clinical severity of the disease.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1:</label>
<caption><p>Timeline of COVID-19 preventions and interventions in South Africa.</p></caption>
<graphic xlink:href="20247361v2_tbl1.tif"/>
</table-wrap>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1:</label>
<caption><p>(a) Total cases by country in the African continent; (b) The 7-day average testing positive rate of COVID-19 in South Africa during the study period.</p></caption>
<graphic xlink:href="20247361v2_fig1.tif"/>
</fig>
</sec>
<sec id="s1c">
<title>Interventions</title>
<p>With a universal goal to &#x2018;flatten the curve&#x2019;, a series of non-pharmaceutical interventions were implemented by the government in South Africa, that have been gradually lifted since early May 2020 [<xref ref-type="bibr" rid="c25">25</xref>]. On March 27, 2020, South Africa adopted a three-week nationwide hard-lockdown (level 5) along with closure of its international borders, which was extended to April 30, 2020. Thereafter, to balance the positive health effects of strict interventions against their economic costs [<xref ref-type="bibr" rid="c1">1</xref>], South Africa began a gradual and phased recovery of economic activities with the lockdown restriction eased to level 4 [<xref ref-type="bibr" rid="c25">25</xref>], allowing inter-provincial travel only for essential services. From June 1, national restrictions were lowered to level 3 allowing for inter-provincial travel and school opening and eased to level 2 and level 1 from August 18 and September 21, 2020 (<xref rid="tbl1" ref-type="table">Table 1</xref>). Face-mask wearing was mandatory in public places at all times, with limitations on gatherings, and sale of alcohol and cigarettes were restricted [<xref ref-type="bibr" rid="c12">12</xref>]. Although these interventions implemented at an early stage had a higher potential for pandemic containment, previous studies [<xref ref-type="bibr" rid="c12">12</xref>, <xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c42">42</xref>] reported a consistently large value for the estimated basic reproduction number (<italic>R</italic><sub>0</sub>) ranging from 2.2 to 3.2 in South Africa by models trained with data in relatively early time windows. Using data observed under various intervention scenarios over a longer period of time, we carry out a thorough investigation to assess the current COVID-19 spread and the effect of these interventions, which will provide valuable insights into the transition dynamics of COVID-19 and intervention deployment in South Africa, and beyond.</p>
</sec>
<sec id="s1d">
<title>Epidemiological models</title>
<p>Since the early days of the pandemic, researchers have responded to the unprecedented public health crisis by providing forecasts and alternative scenarios to inform decision-making, both locally and globally. This has resulted in hundreds of mathematical models of varying complexity. The Susceptible-Infectious-Removed or SIR model [<xref ref-type="bibr" rid="c20">20</xref>] is arguably the most commonly used epidemiological models for modeling the trajectory of an infectious disease. A recent extension of SIR, called extended-SIR or eSIR [<xref ref-type="bibr" rid="c35">35</xref>], was developed to incorporate user-specified non-pharmaceutical interventions and quarantine protocols into a Bayesian hierarchical Beta-Dirichlet state-space model, which was successfully applied to model COVID-19 dynamics in India [<xref ref-type="bibr" rid="c33">33</xref>]. One major advantage of this Bayesian hierarchical structure is that uncertainty associated with all parameters and functions of parameters can be calculated from posterior draws without relying on large-sample approximations [<xref ref-type="bibr" rid="c33">33</xref>]. Extending the simple compartment structure in eSIR model, the SAPHIRE model [<xref ref-type="bibr" rid="c40">40</xref>] delineated the full transmission COVID-19 dynamics in Wuhan, China with additional compartments by introducing unobserved categories [<xref ref-type="bibr" rid="c15">15</xref>].</p>
<p>In this article, we extended the eSIR approach to the eSEIRD model to combine the advantages of the two existing models, using a Bayesian hierarchical structure to introduce additional unobserved compartments and characterize uncertainty in critical epidemiological parameters including basic reproduction number, ascertainment rate and IFR, with input data as observed counts for cases, recoveries and deaths. Furthermore, we applied these three models and compared the results of the eSEIRD model with two of the existing alternatives, namely the eSIR and the SAPHIRE model, with the following primary objectives: (i) characterizing the COVID-19 dynamics from March 15 to December 31, 2020 &#x2013; under different time-varying intervention scenarios; (ii) evaluating the effectiveness of the main non-pharmaceutical interventions such as lockdown, and mandatory wearing of face-mask in public places; (iii) capturing the uncertainty in estimating the ascertainment rate and IFR; and (iv) forecasting the future of COVID-19 spread in South Africa.</p>
<p>The organization of this paper is as follows: we describe the two competing epidemiological models and our proposed extension in &#x00A7;2. The study design and parameter settings for modeling COVID-19 transmission in South Africa are described in &#x00A7;3, and the results and their possible implications are described in &#x00A7;4. We conclude with a discussion of nuances and limitation of the methods and sources of data used here and suggest future directions in &#x00A7;5.</p>
</sec>
</sec>
<sec id="s2">
<label>2</label>
<title>Statistical Methodology</title>
<p>We propose an extension of the eSIR model, called eSEIRD, and compare it against two existing epidemiological methods, the eSIR and SAPHIRE model. In this section, we describe the dynamic systems and the hierarchical models underlying these three epidemiological models. The schematic diagrams for the three compartmental models are shown in <xref rid="fig3" ref-type="fig">Fig. 3</xref> (eSIR and SAPHIRE) and <xref rid="fig4" ref-type="fig">Fig 4</xref> (eSEIRD).</p>
<sec id="s2a">
<label>2.1</label>
<title>eSIR model</title>
<p>The eSIR model assumes the true underlying probabilities of the three compartments susceptible (S), infectious (I) and removed (R) follow a latent Markov transition process and require observed daily proportions of cumulative infected and removed cases as input [<xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c35">35</xref>]. The observed proportions of infected and removed cases on day <italic>t</italic> are denoted by <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline1.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline2.gif"/></alternatives></inline-formula> (the infected and removed counts <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline3.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline4.gif"/></alternatives></inline-formula> divided by total population size <italic>N</italic>) respectively. Further, we denote the true underlying probabilities of the three compartments on day t by <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline5.gif"/></alternatives></inline-formula> and <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline6.gif"/></alternatives></inline-formula>, respectively, and assume that for any <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline7.gif"/></alternatives></inline-formula>. The following set of differential equations describe the dynamic system for the usual SIR model on the true proportions (<xref rid="fig2" ref-type="fig">Fig. 2</xref>).
<disp-formula id="ueqn1">
<alternatives><graphic xlink:href="20247361v2_ueqn1.gif"/></alternatives>
</disp-formula>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2:</label>
<caption><p>The eSIR model with a latent SIR model on the unobserved proportions. Reproduced from [<xref ref-type="bibr" rid="c41">41</xref>].</p></caption>
<graphic xlink:href="20247361v2_fig2.tif"/>
</fig>
where <italic>&#x03B2;</italic> &#x003E; 0 denotes the disease transmission rate, and <italic>&#x03BD;</italic> &#x003E; 0 denotes the removal rate (see <xref rid="fig3" ref-type="fig">Fig. 3(a)</xref> for a schematic representation). The basic reproduction number <italic>R</italic><sub>0</sub> &#x003D; <italic>&#x03B2;/&#x03B3;</italic> indicates the expected number of cases generated by one infected case in the absence of any intervention and assuming that the whole population is susceptible.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3:</label>
<caption><p>Schematic diagram of the two models (a) eSIR; (b) SAPHIRE.</p></caption>
<graphic xlink:href="20247361v2_fig3.tif"/>
</fig>
</sec>
<sec id="s2b">
<title>Hierarchical model</title>
<p>The eSIR model works by assuming that two observed time series of daily proportions of infected and removed cases are emitted from two Beta-Dirichlet state-space model, independent conditionally on the underlying process governed by the Markov SIR process:
<disp-formula id="ueqn2">
<alternatives><graphic xlink:href="20247361v2_ueqn2.gif"/></alternatives>
</disp-formula>
and the Markov process associated with the latent proportions is built as:
<disp-formula id="ueqn3">
<alternatives><graphic xlink:href="20247361v2_ueqn3.gif"/></alternatives>
</disp-formula>
where, <bold><italic>&#x03B8;</italic></bold><sub><italic>t</italic></sub> denotes the vector the true underlying probabilities of the compartments on day <italic>t</italic> whose mean is modeled as an unknown function of the probability vector from the previous time point, along with the transition parameters; <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline8.gif"/></alternatives></inline-formula>. The function <italic>f</italic><sub>1</sub>(&#x00B7;) is then solved as the mean transition probability determined by the SIR dynamic system, using a fourth order Runge-Kutta (RK4) approximation (see supplementary &#x00A7;S.3 for the solution):
<disp-formula id="ueqn4">
<alternatives><graphic xlink:href="20247361v2_ueqn4.gif"/></alternatives>
</disp-formula></p>
<p>Computational details for the eSIR model such as posterior sampling strategy using MCMC algorithm is complemented by the R package publicly available at <ext-link ext-link-type="uri" xlink:href="https://github.com/lilywang1988/eSIR">https://github.com/lilywang1988/eSIR</ext-link>.</p>
</sec>
<sec id="s2c">
<label>2.2</label>
<title>SAPHIRE model</title>
<p>The SAPHIRE model [<xref ref-type="bibr" rid="c15">15</xref>] is an extension of the basic SIR model with additional compartments to allow for unobserved categories such as ascertained, unascertained and hospitalized population. Specifically, in a SAPHIRE model the population is compartmentalized into susceptible (S), exposed (E), presymptomatic infectious (P), ascertained infectious (I), unascertained infectious (A), isolation in hospital (H) and removed (R). Denoting the true underlying accounts of the S, E, P, A, I, H and R compartments on day <italic>t</italic> by <italic>S</italic><sub><italic>t</italic></sub>, <italic>E</italic><sub><italic>t</italic></sub>, <italic>P</italic><sub><italic>t</italic></sub>, <italic>A</italic><sub><italic>t</italic></sub>, <italic>I</italic><sub><italic>t</italic></sub>, <italic>H</italic><sub><italic>t</italic></sub> and <italic>R</italic><sub><italic>t</italic></sub>, respectively, the dynamics of these compartments across time <italic>t</italic> were described by the following set of differential equations (see <xref rid="fig3" ref-type="fig">Fig. 3(b)</xref> for a schematic representation):
<disp-formula id="ueqn5">
<alternatives><graphic xlink:href="20247361v2_ueqn5.gif"/></alternatives>
</disp-formula></p>
<p>To fit the SAPHIRE model, the observed number of ascertained cases in which individuals experienced symptom onset on day <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline9.gif"/></alternatives></inline-formula>, were assumed to follow a Poisson distribution:
<disp-formula id="ueqn6">
<alternatives><graphic xlink:href="20247361v2_ueqn6.gif"/></alternatives>
</disp-formula>
where <italic>P</italic><sub><italic>t</italic>&#x2212;1</sub> denotes the underlying number of pre-symptomatic individuals and r denotes the ascertained rate. For an observation window spanning <italic>t</italic> &#x003D; 1 to <italic>t</italic> &#x003D; <italic>T</italic>, the sampling pseudo-likelihood function for the underlying prevalence parameters is given by:
<disp-formula id="eqn21">
<alternatives><graphic xlink:href="20247361v2_eqn2_1.gif"/></alternatives>
</disp-formula>
after plugging <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline10.gif"/></alternatives></inline-formula> and <bold>X</bold><sub><italic>t</italic></sub> &#x003D; (<italic>S</italic><sub><italic>t</italic></sub>, <italic>E</italic><sub><italic>t</italic></sub>, <italic>P</italic><sub><italic>t</italic></sub>, <italic>A</italic><sub><italic>t</italic></sub>, <italic>I</italic><sub><italic>t</italic></sub>, <italic>H</italic><sub><italic>t</italic></sub>, <italic>R</italic><sub><italic>t</italic></sub>). Here, <italic>X</italic><sub><italic>t</italic></sub> denotes the vector of the underlying population counts of the compartments at time <italic>t</italic>. With the initial values for the compartments <bold>X</bold><sub>0</sub> set at pre-fixed values, the pseudo-likelihood function in (2.1) can be approximated as a function of the parameters of interest, i.e. <bold><italic>&#x03B2;</italic></bold> and <italic>r</italic>, by the following steps:</p>
<list list-type="simple">
<list-item><p><bold>Step 0</bold> The transition parameters <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline11.gif"/></alternatives></inline-formula> and the initial values for the compartments <italic>X</italic><sub>0</sub> &#x003D; (<italic>S</italic><sub>0</sub>, <italic>E</italic><sub>0</sub>, <italic>P</italic><sub>0</sub>, <italic>A</italic><sub>0</sub>, <italic>I</italic><sub>0</sub>, <italic>H</italic><sub>0</sub>, <italic>R</italic><sub>0</sub>) are fixed;</p></list-item>
<list-item><p><bold>Step 1</bold> Use the differential equations to generate the change of each compartment at time <italic>t</italic> &#x003D; 1, i.e. <italic>dX</italic><sub><italic>t</italic></sub><italic>/dt</italic> &#x003D; (<italic>dS</italic><sub><italic>t</italic></sub><italic>/dt, dE</italic><sub><italic>t</italic></sub><italic>/dt, dP</italic><sub><italic>t</italic></sub><italic>/dt, dA</italic><sub><italic>t</italic></sub><italic>/dt, dI</italic><sub><italic>t</italic></sub><italic>/dt, dH</italic><sub><italic>t</italic></sub><italic>/dt, dR</italic><sub><italic>t</italic></sub><italic>/dt</italic>);</p></list-item>
<list-item><p><bold>Step 2</bold> Compute the state values of each compartment at time <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline12.gif"/></alternatives></inline-formula>, and the expected new ascertained cases <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline13.gif"/></alternatives></inline-formula> on day <italic>t</italic>;</p></list-item>
<list-item><p><bold>Step 3</bold> Repeat the step 1-3 for <italic>t</italic> &#x003D; 2, 3, 4, &#x2026;, <italic>T</italic>.</p></list-item>
</list>
<p>For the SAPHIRE model, the MCMC algorithm is implemented with the delayed rejection adaptive metropolis algorithm implemented in the R package BayesianTools (version 0.1.7) to collect posterior samples of the underlying parameters <italic>r</italic> and <italic>&#x03B2;</italic>, then calculate the derived quantities the effective reproduction number <italic>R</italic><sub><italic>e</italic></sub> based on the posterior draws. We refer the reader to [<xref ref-type="bibr" rid="c15">15</xref>] for more details.</p>
</sec>
<sec id="s2d">
<label>2.3</label>
<title>eSEIRD model</title>
<p>Similar to the hierarchical structure used in eSIR model, this eSEIRD model (<italic>vide</italic> <xref rid="fig4" ref-type="fig">Fig. 4</xref>) works by assuming that the true underlying probabilities of the 7 compartments follow a latent Markov transition process which fits not only the count of daily infected, but also the recovered and death counts.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4:</label>
<caption><p>Schematic diagram of the proposed eSEIRD model</p></caption>
<graphic xlink:href="20247361v2_fig4.tif"/>
</fig>
<p>The dynamics of these 7 compartments across time <italic>t</italic> were described by the following set of ordinary differential equations:
<disp-formula id="ueqn7">
<alternatives><graphic xlink:href="20247361v2_ueqn7.gif"/></alternatives>
</disp-formula></p>
<sec id="s2d1">
<title>Hierarchical model</title>
<p>We assumed three observed time series of daily counts of infected, recovered and death cases are emitted from Poisson state-space models, independent conditionally on the underlying process, and the Markov process associated with the latent proportions is constructed as:
<disp-formula id="ueqn8">
<alternatives><graphic xlink:href="20247361v2_ueqn8.gif"/></alternatives>
</disp-formula>
where <italic>X</italic><sub><italic>t</italic></sub> &#x003D; (<italic>S</italic><sub><italic>t</italic></sub>, <italic>E</italic><sub><italic>t</italic></sub>, <italic>A</italic><sub><italic>t</italic></sub>, <italic>I</italic><sub><italic>t</italic></sub>, <italic>H</italic><sub><italic>t</italic></sub>, <italic>R</italic><sub><italic>t</italic></sub>, <italic>D</italic><sub><italic>t</italic></sub>) denotes the vector of the underlying population counts of the 7 compartments; <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline14.gif"/></alternatives></inline-formula> denotes the whole set of parameters where <inline-formula><alternatives><inline-graphic xlink:href="20247361v2_inline15.gif"/></alternatives></inline-formula> denotes the prior for the initial states and <italic>&#x03BA;</italic><sub>1</sub> and <italic>&#x03BA;</italic><sub>2</sub> denote the IFR for non-hospitalized and hospitalized cases, respectively. The function <italic>f</italic><sub>2</sub>(&#x00B7;) is also solved using RK4 approximation as before (see the solution in Supplementary &#x00A7;S.4).
<disp-formula id="ueqn9">
<alternatives><graphic xlink:href="20247361v2_ueqn9.gif"/></alternatives>
</disp-formula></p>
<p>We implemented the MCMC algorithm to sample from the posterior distribution of the underlying parameters <italic>r</italic> and <italic>&#x03B2;</italic>, and calculate the derived quantities:
<disp-formula id="ueqn10">
<alternatives><graphic xlink:href="20247361v2_ueqn10.gif"/></alternatives>
</disp-formula></p>
<p>We obtain the posterior mean estimates and credible intervals for the unknown parameters in the model. Because of the hierarchical structure in the state-space model considered in this model, the posterior sampling can be done in a straightforward fashion like eSIR using the R package rjags.</p>
</sec>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>Modeling COVID-19 transmission dynamics in South Africa</title>
<sec id="s3a">
<label>3.1</label>
<title>Study Design and Data Source</title>
<p>COVID-19 daily time series data for South Africa were extracted from the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [<xref ref-type="bibr" rid="c39">39</xref>] from the onset of the first 50 confirmed case (March 15, 2020) to February 21, 2021. We fitted the models using data up to December 31, 2020 and predicted the state of COVID-19 infection in South Africa in a time window, from January 1 to April 1, 2021. To compare the model prediction performance of different models, we used the symmetric mean absolute percentage error (SMAPE), given by:
<disp-formula id="ueqn11">
<alternatives><graphic xlink:href="20247361v2_ueqn11.gif"/></alternatives>
</disp-formula>
where <italic>A</italic><sub><italic>t</italic></sub> is the observed value and <italic>F</italic><sub><italic>t</italic></sub> is the forecast value in the same time period. This design enabled us to select an optimal modeling strategy for South Africa data and check the robustness of prediction performance across different models.</p>
<sec id="s3a1">
<label>3.1.1</label>
<title>Prior Specification</title>
<p>We describe the prior choices and where appropriate, initial values for the model hyper-parameters in this section and a complete summary and list of notations and assumptions are available in Supplementary Table S.1.1. To begin with, we assumed a constant population size (<italic>N</italic> &#x003D; 57, 779, 622) for all models and fixed a few transition parameters below in the SAPHIRE and eSEIRD model. First, we set an equal number of daily inbound and outbound travelers (<italic>n</italic>), in which <italic>n</italic> &#x003D; 4 &#x00D7; 10<sup>&#x2212;4</sup> <italic>N</italic> from March 15 to 25, 2020 estimated by the number of international travelers to South Africa in 2018[<xref ref-type="bibr" rid="c3">3</xref>], otherwise <italic>n</italic> &#x003D; 0 when border closed, i.e. after March 26. We fixed the transmissibility ratio between unascertained and ascertained cases at <italic>&#x03B1;</italic> &#x003D; 0.55 assuming lower transmissibility for unascertained cases [<xref ref-type="bibr" rid="c2">2</xref>], an incubation period of 5.2 days, and a pre-symptomatic infectious period of <italic>D</italic><sub><italic>p</italic></sub> &#x003D; 2.3 days [<xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c17">17</xref>], implying a latent period of <italic>D</italic><sub><italic>e</italic></sub> &#x003D; 2.9 days. The mean of total infectious period was <italic>D</italic><sub><italic>i</italic></sub> &#x002B; <italic>D</italic><sub><italic>p</italic></sub> &#x003D; 5.2 days [<xref ref-type="bibr" rid="c23">23</xref>], assuming constant infectiousness across the pre-symptomatic and symptomatic phases of ascertained cases [<xref ref-type="bibr" rid="c22">22</xref>], thus, the mean symptomatic infectious period was <italic>D</italic><sub><italic>i</italic></sub> &#x003D; 2.9 days. We set the period of ascertained cases from reporting to hospitalization <italic>D</italic><sub><italic>q</italic></sub> &#x003D; 7 days, the same as the median interval from symptom onset to admission reported [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c13">13</xref>]. The period from being admitted in hospital to discharge or death was assumed as <italic>D</italic><sub><italic>h</italic></sub> &#x003D; 8.6 days [<xref ref-type="bibr" rid="c41">41</xref>]. We fit the SAPHIRE and eSEIRD model in six time periods of 2020: March 15-March 26, March 27- April 30, May 1- May 31, June 1- August 17, August 18-September 20, and September 21-December 31, separated by the change-points of the lockdown strictness level, and denote the ascertained rate and transmission rate in the time periods as <italic>r</italic><sub>1</sub>, <italic>r</italic><sub>2</sub>, <italic>r</italic><sub>3</sub>, <italic>r</italic><sub>4</sub>, <italic>r</italic><sub>5</sub>,<italic>r</italic><sub>6</sub>, <italic>&#x03B2;</italic><sub>1</sub>, <italic>&#x03B2;</italic><sub>2</sub>, <italic>&#x03B2;</italic><sub>3</sub>, <italic>&#x03B2;</italic><sub>4</sub>, <italic>&#x03B2;</italic><sub>5</sub> and <italic>&#x03B2;</italic><sub>6</sub>. In addition, we denote the IFR for non-hospitalized cases <italic>&#x03BA;</italic><sub>11</sub>, <italic>&#x03BA;</italic><sub>12</sub>, <italic>&#x03BA;</italic><sub>13</sub>, <italic>&#x03BA;</italic><sub>14</sub>, <italic>&#x03BA;</italic><sub>15</sub>, <italic>&#x03BA;</italic><sub>16</sub> and for hospitalized cases <italic>&#x03BA;</italic><sub>21</sub>, <italic>&#x03BA;</italic><sub>22</sub>, <italic>&#x03BA;</italic><sub>23</sub>, <italic>&#x03BA;</italic><sub>24</sub>, <italic>&#x03BA;</italic><sub>25</sub>, <italic>&#x03BA;</italic><sub>26</sub> in eSEIRD model.</p>
<sec id="s3a1a">
<title>Choice of Initial states</title>
<p>For the eSIR model, the prior mean for the initial infected/removed proportion was set at the observed infected/removed proportion on March 15, 2020, and that for the susceptible proportion was the total number of the population minus the infected and removed proportions [<xref ref-type="bibr" rid="c35">35</xref>]. For the SAPHIRE model, other than setting prior parameters for initial states, we set the number of initial latent cases <italic>E</italic>(0) was the sum of those ascertained and unascertained cases with onset during March 15-17, 2020 as <italic>D</italic><sub><italic>e</italic></sub> &#x003D; 2.9 days [<xref ref-type="bibr" rid="c15">15</xref>] and the number of initial pre-symptomatic cases <italic>P</italic> (0) was that from March 18-19, 2020 as <italic>D</italic><sub><italic>p</italic></sub> &#x003D; 2.3 days [<xref ref-type="bibr" rid="c15">15</xref>]. The number of ascertained symptomatic cases <italic>I</italic>(0) was assumed as the number of observed infected cases on March 15, 2020 excluding <italic>H</italic>(0), <italic>R</italic>(0) and <italic>D</italic>(0) (the initial numbers for hospitalized, recovered, and deaths). The initial ascertainment rate (<italic>r</italic><sub>0</sub>) was assumed as 0.10 as reported in literature [<xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c6">6</xref>], implying <italic>A</italic>(0) &#x003D; 0.90/0.10<italic>I</italic>(0), and a sensitivity analysis with <italic>r</italic><sub>0</sub> &#x003D; 0.25 was conducted to address weak information for <italic>r</italic><sub>0</sub> obtained in South Africa and variation of <italic>r</italic><sub>0</sub> in different scenarios. <italic>H</italic>(0) was assumed as 50% of the observed ascertained cases on March 9, 2020 (by assuming the period from reported to hospitalized was 7 days [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c13">13</xref>] at the early stage of the pandemic). In addition, we denoted <italic>R</italic>(0) as the sum of observed recovered and death cases on March 15. The number of initial susceptible cases <italic>S</italic>(0) was calculated as the total population (<italic>N</italic>) minus <italic>E</italic>(0), <italic>P</italic> (0), <italic>I</italic>(0), <italic>A</italic>(0) and <italic>R</italic>(0).</p>
<p>In the eSEIRD model, we set the prior mean of initial ascertained, unascertained and hospitalized cases as <italic>I</italic>(0), <italic>A</italic>(0) and <italic>H</italic>(0) discussed above. However, since the latent compartment incorporates the pre-symptomatic cases, the mean of the initial latent cases was set as the sum of those ascertained and unascertained cases with onset during March 15-19, 2020 as <italic>D</italic><sub><italic>e</italic></sub> &#x002B; <italic>D</italic><sub><italic>p</italic></sub> &#x003D; 5.2 days [<xref ref-type="bibr" rid="c15">15</xref>].The prior mean of initial recoveries and deaths were fixed as the number of observed recovered and death cases on March 15, 2020, respectively. Therefore, the prior mean of initial susceptible compartment was set as the total population excluding the mean of other compartments.</p>
</sec>
<sec id="s3a1b">
<title>Prior distributions</title>
<p>In the eSIR model, the log-normal priors were used for the removed rate <italic>&#x03BD;</italic> and the basic reproduction number <italic>R</italic><sub>0</sub>, in particular <italic>&#x03BD;</italic> &#x223C; <italic>LogN</italic> (2.955, 0.910),with <italic>E</italic>(<italic>&#x03BD;</italic>) &#x003D; 0.082 and <italic>SD</italic>(<italic>&#x03BD;</italic>) &#x003D; 0.1 [<xref ref-type="bibr" rid="c35">35</xref>], and <italic>R</italic><sub>0</sub>(= <italic>&#x03B2;/&#x03BD;</italic>) &#x223C; <italic>LogN</italic> (0.582, 0.223) with <italic>E</italic>(<italic>R</italic><sub>0</sub>) &#x003D; 3.2 and <italic>SD</italic>(<italic>R</italic><sub>0</sub>) &#x003D; 1 [<xref ref-type="bibr" rid="c33">33</xref>]. Flat Gamma priors were used for the scale parameters of the Beta-Dirichlet distributions as follows [<xref ref-type="bibr" rid="c33">33</xref>]:
<disp-formula id="ueqn12">
<alternatives><graphic xlink:href="20247361v2_ueqn12.gif"/></alternatives>
</disp-formula></p>
<p>In the eSEIRD model, for the six time periods, all the transmission rates <italic>&#x03B2;</italic><sub>1</sub>, <italic>&#x03B2;</italic><sub>2</sub>, <italic>&#x03B2;</italic><sub>3</sub>, <italic>&#x03B2;</italic><sub>4</sub>, <italic>&#x03B2;</italic><sub>5</sub> and <italic>&#x03B2;</italic><sub>6</sub> were given a <italic>&#x1D4CA;</italic> (0, 2) prior, ascertained rates <italic>r</italic><sub>1</sub>, <italic>r</italic><sub>2</sub>, <italic>r</italic><sub>3</sub>, <italic>r</italic><sub>4</sub>, <italic>r</italic><sub>5</sub> and <italic>r</italic><sub>6</sub> were given Beta(10, 90) prior [<xref ref-type="bibr" rid="c21">21</xref>], the IFR for non-hospitalized cases <italic>&#x03BA;</italic><sub>11</sub>, <italic>&#x03BA;</italic><sub>12</sub>, <italic>&#x03BA;</italic><sub>13</sub>, <italic>&#x03BA;</italic><sub>14</sub>, <italic>&#x03BA;</italic><sub>15</sub>, <italic>&#x03BA;</italic><sub>16</sub> <italic>&#x223C;</italic> Beta(0.03, 2.93) and for hospitalized cases <italic>&#x03BA;</italic><sub>21</sub>, <italic>&#x03BA;</italic><sub>22</sub>, <italic>&#x03BA;</italic><sub>23</sub>, <italic>&#x03BA;</italic><sub>24</sub>, <italic>&#x03BA;</italic><sub>25</sub>, <italic>&#x03BA;</italic><sub>26</sub> <italic>&#x223C;</italic> Beta(0.44, 1.76) with mean equal to 0.1% and 20%, respectively [<xref ref-type="bibr" rid="c41">41</xref>].</p>
<p>In addition, to account for the effect of time-varying contact rate during the prediction period, we set a time-varying contact rate modifier <italic>&#x03C0;</italic>(<italic>t</italic>) in the eSIR and eSEIRD model where <italic>t</italic> from January 1 to April 1, 2021: <italic>&#x03C0;</italic>(<italic>t</italic>) was set as 0.75 since the lockdown was tuned to level 3 after December 28, 2020. Note that the modifier <italic>&#x03C0;</italic>(<italic>t</italic>) is a conjectural quantity and hence must be guided by empirical studies [<xref ref-type="bibr" rid="c33">33</xref>]. Using MCMC sampling method for the eSIR and eSEIRD model, we set the adaptation number to be 10<sup>4</sup>, thinned by 10 draws to reduce auto-correlation, and set a burn-in period of 5 &#x00D7; 10<sup>4</sup> draws under 10<sup>5</sup> iterations for 4 parallel chains.</p>
<p>We fit the SAPHIRE model in six time periods as in the eSEIRD model. We used <italic>r</italic><sub>1</sub> <italic>&#x223C; Beta</italic>(10, 90) and reparameterized <italic>r</italic><sub>2</sub>, <italic>r</italic><sub>3</sub>, <italic>r</italic><sub>4</sub>, <italic>r</italic><sub>5</sub>, and <italic>r</italic><sub>6</sub> by
<disp-formula id="ueqn13">
<alternatives><graphic xlink:href="20247361v2_ueqn13.gif"/></alternatives>
</disp-formula>
where logit(<italic>r</italic>) &#x003D; log(<italic>r</italic>/(1&#x2212;<italic>r</italic>)), and <italic>&#x03B4;</italic><sub><italic>i</italic></sub> &#x223C; &#x1D4A9; (0, 1), for <italic>i</italic> &#x003D; 1, &#x2026;, 5. We use non-informative prior distributions for transmission rates <italic>&#x03B2;</italic><sub><italic>i</italic></sub> &#x223C; <italic>&#x1D4CA;</italic> (0, 2) for <italic>i</italic> &#x003D; 1, &#x2026;, 6 to reflect lack of information about these hyperparameters [<xref ref-type="bibr" rid="c15">15</xref>]. Therefore, <italic>&#x03B2;</italic> and <italic>r</italic> were assumed to follow different distributions for these six time periods. Finally, the effective reproduction number can be derived to be:
<disp-formula id="ueqn14">
<alternatives><graphic xlink:href="20247361v2_ueqn14.gif"/></alternatives>
</disp-formula></p>
<p>We set a burn-in period of 10<sup>5</sup> iterations and continued to run 10<sup>5</sup> iterations with a sampling step size of 10 iterations for the MCMC algorithm of the SAPHIRE model.</p>
<p>A comparison between assumptions of the three models in the Supplementary &#x00A7;S.2. All analyses were conducted in R (version 4.0.0), and source codes are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/umich-cphds/south_africa_modeling">https://github.com/umich-cphds/south_africa_modeling</ext-link>. Posterior mean and corresponding 95% credible interval (95% CrI) were reported for the parameters of interests.</p>
</sec>
</sec>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Results</title>
<p>Here we present the detailed results for South Africa, subdivided into estimation of key epi-demiological parameters, short-term and long-term forecasts, and finally model evaluation in terms prediction and quality of fit.</p>
<sec id="s4a">
<label>4.1</label>
<title>Reproduction number and intervention evaluation</title>
<p>The estimated posterior mean of <italic>R</italic><sub>0</sub> was 1.18 (95%CrI: [1.09, 1.28]) in the eSIR model throughout the training period while in the eSEIRD model, the value of <italic>R</italic><sub>0</sub> started at 3.22 (95%CrI: [3.19, 3.23]) then dropped though still significantly above 1 after the lockdown implementation and increased to 3.27 (95%CrI: [3.27, 3.27]) during the last three months of 2020 (<xref rid="tbl2" ref-type="table">Table 2</xref>). It suggests that the effective contact rate decreased by more than 50% over the lockdown time period and attained the lowest point in its trajectory during August to September, 2020 though the lockdown was eased to a relatively less strict level. On the other hand, the effective reproduction number (<italic>R</italic><sub><italic>e</italic></sub>) in different lockdown periods estimated by the SAPHIRE model demonstrates that a similar trend but the magnitude of the estimated <italic>R</italic><sub><italic>e</italic></sub> decreased dramatically when <italic>r</italic><sub>0</sub> increases from 0.10 to 0.25 (<xref rid="tbl2" ref-type="table">Table 2</xref>; <xref rid="fig5" ref-type="fig">Fig. 5</xref>), possibly suggesting lack of robustness with respect to the choice of initial <italic>r</italic><sub>0</sub>.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2:</label>
<caption><p>The posterior mean and credible intervals of the basic/effective reproduction number (<italic>R</italic><sub>0</sub> or <italic>R</italic><sub><italic>e</italic></sub>) and ascertained rate (<italic>r</italic>) obtained from different models and settings.</p></caption>
<graphic xlink:href="20247361v2_tbl2.tif"/>
</table-wrap>
</sec>
<sec id="s4b">
<label>4.2</label>
<title>Short-term and long-term forecasts</title>
<p>We forecast the total cumulative number of infections, including unascertained cases, in the SAPHIRE model up to February 28, 2021 depending on the time-period considered for estimating the trend. The estimated cumulative number of infections are: (a) 43.3 million if the trend of the least strict lockdown (level 1) was assumed, (b) 36.9-37.8 million if the trend of the lockdown level 2-4 was assumed, and (c) 29.3 million if the trend of strict lockdown was assumed (<italic>r</italic><sub>0</sub> &#x003D; 0.10). However, the short-term forecasts in SAPHIRE model exhibits lack of robustness under different <italic>r</italic><sub>0</sub> settings, for example, when <italic>r</italic><sub>0</sub> &#x003D; 0.25 the estimated cumulative number of infections was 10.6 million if the trend of the least strict lockdown (level 1) was assumed and 0.9 million if the trend of the lockdown level 2 was assumed. In the eSEIRD model, the predicted total cumulative number of cases reach 41.2 million under <italic>r</italic><sub>0</sub> &#x003D; 0.10, and 41.6 million under <italic>r</italic><sub>0</sub> &#x003D; 0.25, along with estimated total deaths counts as 35 or 37 thousand when <italic>r</italic><sub>0</sub> &#x003D; 0.10 or 0.25, respectively, by February 28, 2021. Furthermore, we used the eSEIRD model to forecast the epidemic trajectory for a relatively longer time period, where we found that by April 1, the cumulative number of total infected and deaths would reach roughly 41.3 million (which is around 70% of the total population in South Africa) and 35 thousand, respectively.</p>
</sec>
<sec id="s4c">
<label>4.3</label>
<title>Fitting and prediction performance</title>
<p>All the three candidate models were applied to the COVID-19 data in South Africa with high accuracy as the estimated daily new cases were close to the observed numbers from March to October, 2020 (<xref rid="fig5" ref-type="fig">Fig. 5 (a)-(c)</xref>). However, the eSEIRD model showed a poorer fit during the second pandemic wave in South Africa from November to December 2020, compared to the other two models. The eSIR model performed best in terms of fitting the cumulative ascertained cases with the smallest SMAPE (2.43% when <italic>r</italic><sub>0</sub>=0.10) while the SAPHIRE model had the second smallest training SMAPE (<xref rid="tbl4" ref-type="table">Table 4</xref>). In terms of predictive accuracy, the SAPHIRE model performed best with the smallest SMAPE (4.41% for 15 days and 5.92% for 31 days when <italic>r</italic><sub>0</sub>=0.10) while the eSIR model had the second smallest SMAPE (6.90% for 15 days and 10.78% for 31 days when <italic>r</italic><sub>0</sub>=0.10) (<xref rid="tbl4" ref-type="table">Table 4</xref>). We note that for a few selected important time points, the estimated number of cumulative ascertained infected cases for the eSEIRD model was closest to the observed on December 31, 2020, while the predicted number of cases in the eSIR and SAPHIRE model are closer to the observed on January 31, 2021 (<xref rid="tbl3" ref-type="table">Table 3</xref>). The predictive performances for the three competing models substantiate their credibility in terms of capturing the transmission dynamics for the time-period considered in this study.</p>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3:</label>
<caption><p>Comparison of the models regarding the cumulative ascertained infected and death with the observed (in thousands). Bold-faced entries indicate column winners regarding the closeness to the observed.</p></caption>
<graphic xlink:href="20247361v2_tbl3.tif"/>
</table-wrap>
<table-wrap id="tbl4" orientation="portrait" position="float">
<label>Table 4:</label>
<caption><p>Symmetric mean absolute percentage error (SMAPE) of short-term forecasting. Bold-faced entries indicate column winners regarding prediction performance.</p></caption>
<graphic xlink:href="20247361v2_tbl4.tif"/>
</table-wrap>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5:</label>
<caption><p>(a)-(c) Daily new number of ascertained infections cases estimated by the models compared with observed data: (a) eSIR, (b) SAPHIRE, and (c) eSEIRD; (d) Current pre-symptomatic/unascertained/ascertained infectious in the SAPHIRE model; (e)-(f) Estimated effective reproduction number (<italic>R</italic><sub><italic>e</italic></sub>) and ascertained rate (r) in the SAPHIRE model in four time periods. (Assume initial ascertained rate (<italic>r</italic><sub>0</sub>) equal to 0.10.)</p></caption>
<graphic xlink:href="20247361v2_fig5.tif"/>
</fig>
</sec>
<sec id="s4d">
<label>4.4</label>
<title>Unascertained cases and deaths</title>
<p>As demonstrated by SAPHIRE modeling results in <xref rid="fig5" ref-type="fig">Figure 5 (d)</xref>, the large number of unascertained and pre-symptomatic cases contributed to the rapid spread of disease.The estimated ascertained rates were very low, starting at 8.99% (95% CrI: [8.20%, 9.80%]), decreasing to below 2 during level 5 to level 3 lockdown and then increasing to 15.48% (95% CrI: [15.24%, 15.73%]) during the second pandemic wave in South Africa, respectively (<xref rid="tbl2" ref-type="table">Table 2</xref>; <xref rid="fig5" ref-type="fig">Fig. 5 (f)</xref>). Similarly, in the eSEIRD model, the estimated ascertained rates were also at a very low level (1.65% to 9.17%) and had a similar trend as in SAPHIRE model (<italic>vide</italic> <xref rid="tbl2" ref-type="table">Table 2</xref>). As mentioned before, the estimated ascertained rates were robust with respect to choices for <italic>r</italic><sub>0</sub> in eSEIRD model, but changes drastically in SAPHIRE model with <italic>r</italic><sub>0</sub> changed to 0.25: 95.58% (95%CrI: [76.20%, 99.50%]) before lockdown, between 30.18% to 35.93% during level 5 and 4 lockdown, 95.53% (95%CrI: [81.09%, 99.58%]) in level 3 lockdown, and then decreasing form 33.23% to 18.80% in level 2 to level 1 lockdown.</p>
<p>By the eSEIRD model, the overall IFR was estimated as 0.06% (95%CrI: [0.04%, 0.22%]) throughout the whole time period taking the reported and unreported cases and deaths into account while the observed overall case fatality ratio was estimated as 2.88% (95% CrI: [2.45%, 6.01%]) (<xref rid="fig6" ref-type="fig">Fig. 6</xref>). Furthermore, the eSEIRD model provided Bayesian estimates for IFR and deaths among hospitalized and non-hospitalized cases. The estimated IFR for hospitalized cases was 15.28% (95%CrI: [0.01%, 69.10%]) before lockdown and increased to 65.86% (95%CrI: [51.00%, 82.91%]) in the first time period of lockdown. After that, the IFR for hospitalized cases decreased from 22.9% (95%CrI: [20.75%, 25.18%]) to 7.46% (95%CrI: [7.46%, 7.71%]) during May to September. By the end of 2020, it again increased to 19.25% (95%CrI: [18.82%, 19.69%]). The IFR of hospitalized cases was much larger than that of non-hospitalized cases (less than 0.01%),and these estimates were robust to the choice of <italic>r</italic><sub>0</sub>.</p>
<fig id="fig6" position="float" fig-type="figure">
<label>Figure 6:</label>
<caption><p>Case fatality ratio (CFR) and estimated infection fatality ratio (IFR) in the eSEIRD model. CFR =(Number of reported deaths)/(Number of reported deaths and recovered) ; IFR1 &#x003D; (Number of reported deaths)/(Number of of reported and unreported cases); and IFR2 &#x003D; (Number of reported and unreported deaths)/(Number of of reported and unreported cases)[<xref ref-type="bibr" rid="c20">20</xref>].</p></caption>
<graphic xlink:href="20247361v2_fig6.tif"/>
</fig>
</sec>
</sec>
<sec id="s5">
<label>5</label>
<title>Discussion</title>
<p>In this paper, we propose a new infectious disease forecasting model that incorporates the unascertained cases, population movement over different time periods, and the effect of intervention strategies in a unified way and use it to investigate the spread of COVID-19 in South Africa, the hardest hit country on the African continent. The methodological tools developed here can be used to estimate the IFR as well as estimate actual COVID-19 deaths from the reported death counts.</p>
<p>The lockdown intervention and mandatory face-mask wearing in public places employed in South Africa seemed to contain the spread of COVID-19 effectively as the <italic>R</italic><sub><italic>e</italic></sub> decreased dramatically initially but increased later following the relaxation of lockdown stringency afterwards. However, the <italic>R</italic><sub><italic>e</italic></sub> was consistently above 1 throughout the whole period analyzed, which implies the interventions failed to dampen the transmission fully, further substantiated by the basic reproduction number estimates in the eSEIRD model as well. This agrees with the public health experts advice of carefully implemented intervention policies while taking account their potential economic costs [<xref ref-type="bibr" rid="c37">37</xref>].</p>
<p>We also found that the estimated ascertainment rate is very low in South Africa compared to that reported for many other countries [<xref ref-type="bibr" rid="c15">15</xref>, <xref ref-type="bibr" rid="c4">4</xref>, <xref ref-type="bibr" rid="c32">32</xref>], also implied by the low testing rate and high testing positive rate in South Africa. As of February 21, the number of total tests conducted is 8.9 million, suggesting that about 15.4% population were tested [<xref ref-type="bibr" rid="c18">18</xref>]. Furthermore, the estimated ascertainment rate is consistent with that in other multiple global epicenters under severe pandemic of COVID-19, such as France, the United States, Italy and Spain in March [<xref ref-type="bibr" rid="c21">21</xref>]. The large number of unascertained cases is likely to contribute significantly to the continuing spread of COVID-19 [<xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c19">19</xref>]. Our findings suggest that there are around 70% of the total population in South Africa infected by December 31, 2020, which is roughly consistent with the seroprevalence survey conducted in South Africa that the estimated prevalence is around 63% in the Eastern Cape, one of the pandemic centers in South Africa [<xref ref-type="bibr" rid="c38">38</xref>]. Despite the potential high prevalence of COVID, the second wave of pandemic appeared in South Africa and other pandemic centers like Brazil, which may due to the waning immunity against infection with the time to the first wave increasing, and the coronavirus lineages might have higher inherent transmissibility than the pre-existing lineages and be able to evade the immunity generated in response to previous infection [<xref ref-type="bibr" rid="c34">34</xref>]. To prevent potential resurgence in the future, addition to the strict interventions, more surveillance testing and effective testing strategies under conditions of limited test availability, such as contact tracing of the contacts and confirmed cases, will be helpful to curtail the pandemic in South Africa [<xref ref-type="bibr" rid="c12">12</xref>].</p>
<p>Although highly transmissible and poorly ascertained, the COVID-19 IFR is estimated as 0.06% taking account of unreported cases and deaths in South Africa, comparable to the estimates in other locations with similar low mortality rate based on serological data [<xref ref-type="bibr" rid="c19">19</xref>]. The low IFR may be due to the South African population being relatively young which lessens the fatal impact on general population to some extent [<xref ref-type="bibr" rid="c36">36</xref>]. Our estimates of the IFR of hospitalized cases are much higher than that for non-hospitalized cases, suggesting that the most severe cases may have been admitted to hospitals despite the relatively lack of the testing arrangements. The very low estimated IFR for the non-hospitalized cases also imply that the degree of under-reporting for death by the model is very low (0.24% by April 1, 2021), and likely to be affected by the same factors.</p>
<sec id="s5a">
<title>Comparison of the models</title>
<p>The eSIR and the SAPHIRE model have been successfully applied to the data in India and Wuhan, China, separately [<xref ref-type="bibr" rid="c35">35</xref>, <xref ref-type="bibr" rid="c13">13</xref>]. Although SAPHIRE model exhibits superior prediction performance on COVID-19 cases, the estimates of underlying paratemters and unascertained cases showed lack of robustness to the change of initial ascertainment rate <italic>r</italic><sub>0</sub>. On the other hand, the eSIR model has the best estimation capability in terms of the ascertained cases but a relatively poor predictive capacity for capturing the change in the trend of the epidemic in time for neglecting some important clinical characteristics. The eSEIRD model also has a good fitting performance but a relatively poor prediction capacity. <xref rid="tbl2" ref-type="table">Table 2</xref> also suggests that the estimates in eSEIRD model are robust estimated compared to the SAPHIRE model, probably an artifact of the Bayesian hierarchical model used.</p>
</sec>
<sec id="s5b">
<title>Strengths and Limitations</title>
<p>The key methodological innovation for the proposed method is revealed by a quick comparison between the schematic diagrams for eSEIRD model (<xref rid="fig4" ref-type="fig">Fig. 4</xref>) and SAPHIRE model (<xref rid="fig3" ref-type="fig">Fig. 3(b)</xref>). Broadly speaking, eSEIRD incorporates <italic>&#x03C0;</italic>(<italic>t</italic>), the transmission rate modifier as well as splits the &#x2018;removed&#x2019; compartment into &#x2018;recovered&#x2019; and &#x2018;deaths&#x2019; while accounting for separate rates for ascertained, unascertained and hospitalized cases.</p>
<p>Despite the superior performance and robustness exhibited by the models examined here, there are some important limitations. First, the model assumptions were elicited from previous reports from other countries because of the lack of such information for South Africa, especially the fixed values for hyper-parameters. Though the estimation of parameters and prediction of infections seem to be robust to these assumptions to some extent, the inference and prediction would be much more convincing when based on accurate information specific to South Africa.</p>
<p>Second, the ascertained rate was assumed to follow the same distribution in a long time period in the eSEIRD model although in reality it might be time-varying depending on the accumulating knowledge and deployment of clinical resources for COVID-19, given the spatial variation within South Africa regarding the population density and movement, as well as regarding location of COVID-19 hotspots and hospital resources. Further, the population density is highly heterogeneous in different regions in South Africa with higher concentration near high-density economic hub cities, such as Cape Town and Durban. COVID-19 cases are also diversely spread. For instant, Gauteng Province is a very small, highly dense province with roughly 30% of total cases in the nation, and 49% of confirmed cases cluster in KwaZulu-Natal, Eastern Cape and Western Cape Province. In addition, the seroprevalence study also suggested that the prevalence may vary from city to city: 63% in the Eastern Cape, 52% in the KwaZulu Natal and 32% in the Northern Cape [<xref ref-type="bibr" rid="c38">38</xref>]. Without considering these heterogeneities and potential confounding factors in individual region, the conclusion on the national data might be biased. The burden of HIV and tuberculosis comorbidity, particularly among the less privileged socio-economic population, also adds to the complexity of analyzing the COVID-19 data from South Africa [<xref ref-type="bibr" rid="c5">5</xref>].</p>
<p>Third, in this paper we implicitly assumed that the recovered cases would not be infected again but it is still inconclusive based on extant research for COVID-19 [<xref ref-type="bibr" rid="c14">14</xref>]. It might lead to a resurgence if this assumption is not valid and the interventions are totally lifted. Thus, it might be necessary to conduct more national serological surveys on COVID-19 among the general population in South Africa to confirm the national, as well as provincial, seroprevalence. Such large-scale studies will also provide more powerful evidence to examine the evolving benefits of non-pharmaceutical interventions decisions and provide guidance to manage provincial level disparity.</p>
<p>Finally, from the early stage of this pandemic to now, there has been an explosive development in COVID-19 forecasting models but systematic comparison between the available models in terms of out-of-sample prediction and inference has been rare (see e.g. [<xref ref-type="bibr" rid="c11">11</xref>]) as are carefully done simulation studies where the &#x2018;ground truth&#x2019; is known. Lack of simulation studies comparing the candidate methods is also a limiting feature of this paper, and we hope to pursue this in a future endeavor.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material>
<label>Supplementary materials</label>
<media xlink:href="supplements/247361_file03.pdf" />
</supplementary-material>
</sec>
</body>
<back>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>The data of this study are openly available in the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University at https://github.com/CSSEGISandData/COVID-19.</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://github.com/CSSEGISandData/COVID-19">https://github.com/CSSEGISandData/COVID-19</ext-link>
</p>
</sec>
<ack>
<label>5.1</label>
<title>Acknowledgements</title>
<p>This work was supported by grants from the National Science Foundation [grant numbers DMS-1712933 (to B.M.) and DMS-2015460 (to J.D.)] and from National Institute of Health &#x2013; 1 R01 HG008773-01 (to B.M.). The first and second author (X.G. and B.M.) would also like to thank the Center for Precision Health Data Sciences at the University of Michigan School of Public Health, The University of Michigan Rogel Cancer Center and the Michigan Institute of Data Science for internal funding that supported this research.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>[1]</label><mixed-citation publication-type="journal"><string-name><given-names>Channing</given-names> <surname>Arndt</surname></string-name>, <string-name><given-names>Rob</given-names> <surname>Davies</surname></string-name>, <string-name><given-names>Sherwin</given-names> <surname>Gabriel</surname></string-name>, <string-name><given-names>Laurence</given-names> <surname>Harris</surname></string-name>, <string-name><given-names>Konstantin</given-names> <surname>Makrelov</surname></string-name>, <string-name><given-names>Sherman</given-names> <surname>Robinson</surname></string-name>, <string-name><given-names>Stephanie</given-names> <surname>Levy</surname></string-name>, <string-name><given-names>Witness</given-names> <surname>Simbanegavi</surname></string-name>, <string-name><given-names>Dirk</given-names> <surname>van Seventer</surname></string-name>, and <string-name><given-names>Lillian</given-names> <surname>Anderson</surname></string-name>. <article-title>Covid-19 lockdowns, income distribution, and food security: An analysis for South Africa</article-title>. <source>Global Food Security</source>, <volume>26</volume>:<fpage>100410</fpage>, <month>September</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c2"><label>[2]</label><mixed-citation publication-type="other"><collab>The World Bank</collab>. <source>International tourism, number of arrivals - South Africa</source>.</mixed-citation></ref>
<ref id="c3"><label>[3]</label><mixed-citation publication-type="other"><collab>The World Bank</collab>. <source>International tourism, number of arrivals - south africa</source>, <year>2020</year>.</mixed-citation></ref>
<ref id="c4"><label>[4]</label><mixed-citation publication-type="journal"><string-name><given-names>Rupam</given-names> <surname>Bhattacharyya</surname></string-name>, <string-name><given-names>Ritwik</given-names> <surname>Bhaduri</surname></string-name>, <string-name><given-names>Ritoban</given-names> <surname>Kundu</surname></string-name>, <string-name><given-names>Maxwell</given-names> <surname>Salvatore</surname></string-name>, and <string-name><given-names>Bhramar</given-names> <surname>Mukherjee</surname></string-name>. <article-title>Reconciling epidemiological models with misclassified case-counts for SARS-CoV-2 with seroprevalence surveys: A case study in Delhi, India</article-title>. <source>medRxiv</source>, <year>2020</year>. Publisher: Cold Spring Harbor Laboratory Press.</mixed-citation></ref>
<ref id="c5"><label>[5]</label><mixed-citation publication-type="other"><string-name><given-names>Andrew</given-names> <surname>Boulle</surname></string-name>, <string-name><given-names>Mary-Ann</given-names> <surname>Davies</surname></string-name>, <string-name><given-names>Hannah</given-names> <surname>Hussey</surname></string-name>, <string-name><given-names>Muzzammil</given-names> <surname>Ismail</surname></string-name>, <string-name><given-names>Erna</given-names> <surname>Morden</surname></string-name>, <string-name><given-names>Ziyanda</given-names> <surname>Vundle</surname></string-name>, <string-name><given-names>Virginia</given-names> <surname>Zweigenthal</surname></string-name>, <string-name><given-names>Hassan</given-names> <surname>Mahomed</surname></string-name>, <string-name><given-names>Masudah</given-names> <surname>Paleker</surname></string-name>, <string-name><given-names>David</given-names> <surname>Pienaar</surname></string-name>, <etal>et al.</etal> <article-title>Risk factors for covid-19 death in a population cohort study from the western cape province, south africa</article-title>. <source>Clinical infectious diseases: an official publication of the Infectious Diseases Society of America</source>.</mixed-citation></ref>
<ref id="c6"><label>[6]</label><mixed-citation publication-type="other"><collab>U.S. CDC</collab>. <source>Provisional Death Counts for Coronavirus Disease 2019 (COVID-19)</source>.</mixed-citation></ref>
<ref id="c7"><label>[7]</label><mixed-citation publication-type="other"><string-name><given-names>Diletta</given-names> <surname>Cereda</surname></string-name>, <string-name><given-names>Marcello</given-names> <surname>Tirani</surname></string-name>, <string-name><given-names>Francesca</given-names> <surname>Rovida</surname></string-name>, <string-name><given-names>Vittorio</given-names> <surname>Demicheli</surname></string-name>, <string-name><given-names>Marco</given-names> <surname>Ajelli</surname></string-name>, <string-name><given-names>Piero</given-names> <surname>Poletti</surname></string-name>, <string-name><given-names>Fr&#x00E9;d&#x00E9;ric</given-names> <surname>Trentini</surname></string-name>, <string-name><given-names>Giorgio</given-names> <surname>Guzzetta</surname></string-name>, <string-name><given-names>Valentina</given-names> <surname>Marziano</surname></string-name>, <string-name><given-names>Angelica</given-names> <surname>Barone</surname></string-name>, <etal>et al.</etal> <article-title>The early phase of the covid-19 outbreak in lombardy, italy</article-title>. <source>arXiv preprint</source> arXiv:<pub-id pub-id-type="arxiv">2003.09320</pub-id>, <year>2020</year>.</mixed-citation></ref>
<ref id="c8"><label>[8]</label><mixed-citation publication-type="other"><collab>South African COVID-19 Modelling Consortium</collab>. <source>Estimating cases for COVID-19 in South Africa Long-term national projections</source>. <month>May</month>, <year>2020</year>.</mixed-citation></ref>
<ref id="c9"><label>[9]</label><mixed-citation publication-type="other"><string-name><given-names>Luke</given-names> <surname>Daniel</surname></string-name>. <source>New booze, curfew rules for Covid hotspots: Govt to take decision today</source>, <year>2020</year>.</mixed-citation></ref>
<ref id="c10"><label>[10]</label><mixed-citation publication-type="journal"><string-name><given-names>Luca</given-names> <surname>Ferretti</surname></string-name>, <string-name><given-names>Chris</given-names> <surname>Wymant</surname></string-name>, <string-name><given-names>Michelle</given-names> <surname>Kendall</surname></string-name>, <string-name><given-names>Lele</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>Anel</given-names> <surname>Nurtay</surname></string-name>, <string-name><given-names>Lucie</given-names> <surname>Abeler-D&#x00F6;rner</surname></string-name>, <string-name><given-names>Michael</given-names> <surname>Parker</surname></string-name>, <string-name><given-names>David</given-names> <surname>Bonsall</surname></string-name>, and <string-name><given-names>Christophe</given-names> <surname>Fraser</surname></string-name>. <article-title>Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing</article-title>. <source>Science</source>, <volume>368</volume>(<issue>6491</issue>):<fpage>eabb6936</fpage>, <month>May</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c11"><label>[11]</label><mixed-citation publication-type="other"><string-name><given-names>Joseph</given-names> <surname>Friedman</surname></string-name>, <string-name><given-names>Patrick</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Emmanuela</given-names> <surname>Gakidou</surname></string-name>, <article-title>IHME COVID, and Model Comparison Team. Predictive performance of international covid-19 mortality forecasting models</article-title>. <source>medRxiv</source>, <year>2020</year>.</mixed-citation></ref>
<ref id="c12"><label>[12]</label><mixed-citation publication-type="journal"><string-name><given-names>Salisu M.</given-names> <surname>Garba</surname></string-name>, <string-name><given-names>Jean M.-S.</given-names> <surname>Lubuma</surname></string-name>, and <string-name><given-names>Berge</given-names> <surname>Tsanou</surname></string-name>. <article-title>Modeling the transmission dynamics of the COVID-19 Pandemic in South Africa</article-title>. <source>Mathematical Biosciences</source>, <volume>328</volume>:<fpage>108441</fpage>, <month>October</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c13"><label>[13]</label><mixed-citation publication-type="journal"><string-name><given-names>Shikha</given-names> <surname>Garg</surname></string-name>. <article-title>Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019&#x2014;COVID-NET, 14 States</article-title>, <month>March</month> <fpage>1</fpage>&#x2013;<lpage>30</lpage>, 2020. <source>MMWR. Morbidity and mortality weekly report</source>, <volume>69</volume>, <year>2020</year>.</mixed-citation></ref>
<ref id="c14"><label>[14]</label><mixed-citation publication-type="other"><string-name><given-names>Marie</given-names> <surname>Gousseff</surname></string-name>, <string-name><given-names>Pauline</given-names> <surname>Penot</surname></string-name>, <string-name><given-names>Laure</given-names> <surname>Gallay</surname></string-name>, <string-name><given-names>Dominique</given-names> <surname>Batisse</surname></string-name>, <string-name><given-names>Nicolas</given-names> <surname>Benech</surname></string-name>, <string-name><given-names>Kevin</given-names> <surname>Bouiller</surname></string-name>, <string-name><given-names>Rocco</given-names> <surname>Collarino</surname></string-name>, <string-name><given-names>Anne</given-names> <surname>Conrad</surname></string-name>, <string-name><given-names>Dorsaf</given-names> <surname>Slama</surname></string-name>, <string-name><given-names>C&#x00E9;dric</given-names> <surname>Joseph</surname></string-name>, <string-name><given-names>Adrien</given-names> <surname>Lemaignen</surname></string-name>, <string-name><given-names>Franccois-Xavier</given-names> <surname>Lescure</surname></string-name>, <string-name><given-names>Bruno</given-names> <surname>Levy</surname></string-name>, <string-name><given-names>Matthieu</given-names> <surname>Mahevas</surname></string-name>, <string-name><given-names>Bruno</given-names> <surname>Pozzetto</surname></string-name>, <string-name><given-names>Nicolas</given-names> <surname>Vignier</surname></string-name>, <string-name><given-names>Benjamin</given-names> <surname>Wyplosz</surname></string-name>, <string-name><given-names>Dominique</given-names> <surname>Salmon</surname></string-name>, <string-name><given-names>Francois</given-names> <surname>Goehringer</surname></string-name>, and <string-name><given-names>Elisabeth</given-names> <surname>Botelho-Nevers</surname></string-name>. <article-title>Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?</article-title> <source>Journal of Infection</source>, <month>June</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c15"><label>[15]</label><mixed-citation publication-type="journal"><string-name><given-names>Xingjie</given-names> <surname>Hao</surname></string-name>, <string-name><given-names>Shanshan</given-names> <surname>Cheng</surname></string-name>, <string-name><given-names>Degang</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>Tangchun</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>Xihong</given-names> <surname>Lin</surname></string-name>, and <string-name><given-names>Chaolong</given-names> <surname>Wang</surname></string-name>. <article-title>Reconstruction of the full transmission dynamics of COVID-19 in Wuhan</article-title>. <source>Nature</source>, pages <fpage>1</fpage>&#x2013;<lpage>5</lpage>, <month>July</month> <year>2020</year>. Publisher: Nature Publishing Group.</mixed-citation></ref>
<ref id="c16"><label>[16]</label><mixed-citation publication-type="journal"><string-name><given-names>Jingjing</given-names> <surname>He</surname></string-name>, <string-name><given-names>Yifei</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>Richeng</given-names> <surname>Mao</surname></string-name>, and <string-name><given-names>Jiming</given-names> <surname>Zhang</surname></string-name>. <article-title>Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis</article-title>. <source>J Med Virol</source>, page <pub-id pub-id-type="doi">10.1002/jmv.26326</pub-id>, <month>July</month> <year>2020</year>. Publisher: John Wiley and Sons Inc.</mixed-citation></ref>
<ref id="c17"><label>[17]</label><mixed-citation publication-type="journal"><string-name><given-names>Xi</given-names> <surname>He</surname></string-name>, <string-name><given-names>Eric H. Y.</given-names> <surname>Lau</surname></string-name>, <string-name><given-names>Peng</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>Xilong</given-names> <surname>Deng</surname></string-name>, <string-name><given-names>Jian</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Xinxin</given-names> <surname>Hao</surname></string-name>, <string-name><given-names>Yiu Chung</given-names> <surname>Lau</surname></string-name>, <string-name><given-names>Jessica Y.</given-names> <surname>Wong</surname></string-name>, <string-name><given-names>Yujuan</given-names> <surname>Guan</surname></string-name>, <string-name><given-names>Xinghua</given-names> <surname>Tan</surname></string-name>, <string-name><given-names>Xiaoneng</given-names> <surname>Mo</surname></string-name>, <string-name><given-names>Yanqing</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Baolin</given-names> <surname>Liao</surname></string-name>, <string-name><given-names>Weilie</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Fengyu</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>Qing</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Mingqiu</given-names> <surname>Zhong</surname></string-name>, <string-name><given-names>Yanrong</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>Lingzhai</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>Fuchun</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Benjamin J.</given-names> <surname>Cowling</surname></string-name>, <string-name><given-names>Fang</given-names> <surname>Li</surname></string-name>, and <string-name><given-names>Gabriel M.</given-names> <surname>Leung</surname></string-name>. <article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title>. <source>Nature Medicine</source>, <volume>26</volume>(<issue>5</issue>):<fpage>672</fpage>&#x2013;<lpage>675</lpage>, <month>May</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c18"><label>[18]</label><mixed-citation publication-type="other"><collab>Our World in Data</collab>. <source>Coronavirus (COVID-19) Testing</source>.</mixed-citation></ref>
<ref id="c19"><label>[19]</label><mixed-citation publication-type="journal"><string-name><given-names>John</given-names> <surname>Ioannidis</surname></string-name>. <article-title>The infection fatality rate of COVID-19 inferred from seroprevalence data</article-title>. <source>medRxiv</source>, <year>2020</year>. Publisher: Cold Spring Harbor Laboratory Press.</mixed-citation></ref>
<ref id="c20"><label>[20]</label><mixed-citation publication-type="journal"><string-name><given-names>William Ogilvy</given-names> <surname>Kermack</surname></string-name>, <string-name><given-names>A. G.</given-names> <surname>McKendrick</surname></string-name>, and <string-name><given-names>Gilbert Thomas</given-names> <surname>Walker.</surname></string-name> <article-title>A contribution to the mathematical theory of epidemics</article-title>. <source>Proceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character</source>, <volume>115</volume>(<issue>772</issue>):<fpage>700</fpage>&#x2013;<lpage>721</lpage>, <month>August</month> <year>1927</year>. Publisher: Royal Society.</mixed-citation></ref>
<ref id="c21"><label>[21]</label><mixed-citation publication-type="journal"><string-name><given-names>Hien</given-names> <surname>Lau</surname></string-name>, <string-name><given-names>Tanja</given-names> <surname>Khosrawipour</surname></string-name>, <string-name><given-names>Piotr</given-names> <surname>Kocbach</surname></string-name>, <string-name><given-names>Hirohito</given-names> <surname>Ichii</surname></string-name>, <string-name><given-names>Jacek</given-names> <surname>Bania</surname></string-name>, and <string-name><given-names>Veria</given-names> <surname>Khosrawipour</surname></string-name>. <article-title>Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters</article-title>. <source>Pulmonology</source>, <year>2020</year>. ISBN: <isbn>2531-0437</isbn> Publisher: Elsevier.</mixed-citation></ref>
<ref id="c22"><label>[22]</label><mixed-citation publication-type="journal"><string-name><given-names>Qun</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Xuhua</given-names> <surname>Guan</surname></string-name>, <string-name><given-names>Peng</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>Xiaoye</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Lei</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>Yeqing</given-names> <surname>Tong</surname></string-name>, <string-name><given-names>Ruiqi</given-names> <surname>Ren</surname></string-name>, <string-name><given-names>Kathy S.M.</given-names> <surname>Leung</surname></string-name>, <string-name><given-names>Eric H.Y.</given-names> <surname>Lau</surname></string-name>, <string-name><given-names>Jessica Y.</given-names> <surname>Wong</surname></string-name>, <string-name><given-names>Xuesen</given-names> <surname>Xing</surname></string-name>, <string-name><given-names>Nijuan</given-names> <surname>Xiang</surname></string-name>, <string-name><given-names>Yang</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>Chao</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Qi</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Dan</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Tian</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Jing</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>Man</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Wenxiao</given-names> <surname>Tu</surname></string-name>, <string-name><given-names>Chuding</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Lianmei</given-names> <surname>Jin</surname></string-name>, <string-name><given-names>Rui</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>Qi</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Suhua</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>Rui</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Hui</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Yinbo</given-names> <surname>Luo</surname></string-name>, <string-name><given-names>Yuan</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Ge</given-names> <surname>Shao</surname></string-name>, <string-name><given-names>Huan</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Zhongfa</given-names> <surname>Tao</surname></string-name>, <string-name><given-names>Yang</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>Zhiqiang</given-names> <surname>Deng</surname></string-name>, <string-name><given-names>Boxi</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Zhitao</given-names> <surname>Ma</surname></string-name>, <string-name><given-names>Yanping</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Guoqing</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>Tommy T.Y.</given-names> <surname>Lam</surname></string-name>, <string-name><given-names>Joseph T.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>George F.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>Benjamin J.</given-names> <surname>Cowling</surname></string-name>, <string-name><given-names>Bo</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>Gabriel M.</given-names> <surname>Leung</surname></string-name>, and <string-name><given-names>Zijian</given-names> <surname>Feng</surname></string-name>. <article-title>Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus&#x2013;Infected Pneumonia</article-title>. <source>N Engl J Med</source>, <volume>382</volume>(<issue>13</issue>):<fpage>1199</fpage>&#x2013;<lpage>1207</lpage>, <month>January</month> <year>2020</year>. Publisher: Massachusetts Medical Society.</mixed-citation></ref>
<ref id="c23"><label>[23]</label><mixed-citation publication-type="journal"><string-name><given-names>Ruiyun</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Sen</given-names> <surname>Pei</surname></string-name>, <string-name><surname>Bin</surname> <given-names>Chen</given-names></string-name>, <string-name><given-names>Yimeng</given-names> <surname>Song</surname></string-name>, <string-name><given-names>Tao</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Wan</given-names> <surname>Yang</surname></string-name>, and <string-name><given-names>Jeffrey</given-names> <surname>Shaman</surname></string-name>. <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2</article-title>). <source>Science</source>, <volume>368</volume>(<issue>6490</issue>):<fpage>489</fpage>&#x2013;<lpage>493</lpage>, <month>May</month> <year>2020</year>. Publisher: American Association for the Advancement of Science Section: Research Article.</mixed-citation></ref>
<ref id="c24"><label>[24]</label><mixed-citation publication-type="journal"><string-name><given-names>Zindoga</given-names> <surname>Mukandavire</surname></string-name>, <string-name><given-names>Farai</given-names> <surname>Nyabadza</surname></string-name>, <string-name><given-names>Noble J.</given-names> <surname>Malunguza</surname></string-name>, <string-name><given-names>Diego F.</given-names> <surname>Cuadros</surname></string-name>, <string-name><given-names>Tinevimbo</given-names> <surname>Shiri</surname></string-name>, and <string-name><given-names>Godfrey</given-names> <surname>Musuka</surname></string-name>. <article-title>Quantifying early COVID-19 outbreak transmission in South Africa and exploring vaccine efficacy scenarios</article-title>. <source>PLOS ONE</source>, <volume>15</volume>(<issue>7</issue>):<fpage>e0236003</fpage>, <month>July</month> <year>2020</year>. Publisher: Public Library of Science.</mixed-citation></ref>
<ref id="c25"><label>[25]</label><mixed-citation publication-type="other"><collab>South Africa Department of Health</collab>. <source>COVID-19 Online Resource and News Portal</source>.</mixed-citation></ref>
<ref id="c26"><label>[26]</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>Situation reports on COVID-19 outbreak - Sitrep 24, 12</source> <month>August</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c27"><label>[27]</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>COVID-19 virtual press conference on 30 March 2020, 2020</source>.</mixed-citation></ref>
<ref id="c28"><label>[28]</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>Estimating mortality from COVID-19: scientific brief, 4 August 2020. Technical report, World Health Organization</source>, <year>2020</year>.</mixed-citation></ref>
<ref id="c29"><label>[29]</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)</source>, <year>2020</year>.</mixed-citation></ref>
<ref id="c30"><label>[30]</label><mixed-citation publication-type="other"><collab>World Health Organization</collab>. <source>South africa: Who coronavirus disease (covid-19) dash-board. Technical report</source>, <month>February</month> <year>2021</year>.</mixed-citation></ref>
<ref id="c31"><label>[31]</label><mixed-citation publication-type="journal"><string-name><given-names>Dave</given-names> <surname>Osthus</surname></string-name>, <string-name><given-names>Kyle S.</given-names> <surname>Hickmann</surname></string-name>, <string-name><given-names>Petructa C.</given-names> <surname>Caragea</surname></string-name>, <string-name><given-names>Dave</given-names> <surname>Higdon</surname></string-name>, and <string-name><given-names>Sara Y.</given-names> <surname>Del Valle</surname></string-name>. <article-title>Forecasting seasonal influenza with a state-space SIR model</article-title>. <source>Ann. Appl. Stat</source>., <volume>11</volume>(<issue>1</issue>):<fpage>202</fpage>&#x2013;<lpage>224</lpage>, <month>March</month> <year>2017</year>. Publisher: Institute of Mathematical Statistics.</mixed-citation></ref>
<ref id="c32"><label>[32]</label><mixed-citation publication-type="journal"><string-name><given-names>Hazhir</given-names> <surname>Rahmandad</surname></string-name>, <string-name><given-names>Tse Yang</given-names> <surname>Lim</surname></string-name>, and <string-name><given-names>John</given-names> <surname>Sterman</surname></string-name>. <article-title>Estimating COVID-19 under-reporting across 86 nations: implications for projections and control</article-title>. <source>medRxiv</source>, <year>2020</year>. Publisher: Cold Spring Harbor Laboratory Press.</mixed-citation></ref>
<ref id="c33"><label>[33]</label><mixed-citation publication-type="journal"><string-name><given-names>Debashree</given-names> <surname>Ray</surname></string-name>, <string-name><given-names>Maxwell</given-names> <surname>Salvatore</surname></string-name>, <string-name><given-names>Rupam</given-names> <surname>Bhattacharyya</surname></string-name>, <string-name><given-names>Lili</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Jiacong</given-names> <surname>Du</surname></string-name>, <string-name><given-names>Shariq</given-names> <surname>Mohammed</surname></string-name>, <string-name><given-names>Soumik</given-names> <surname>Purkayastha</surname></string-name>, <string-name><given-names>Aritra</given-names> <surname>Halder</surname></string-name>, <string-name><given-names>Alexander</given-names> <surname>Rix</surname></string-name>, <string-name><given-names>Daniel</given-names> <surname>Barker</surname></string-name>, <string-name><given-names>Michael</given-names> <surname>Kleinsasser</surname></string-name>, <string-name><given-names>Yiwang</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>Debraj</given-names> <surname>Bose</surname></string-name>, <string-name><given-names>Peter</given-names> <surname>Song</surname></string-name>, <string-name><given-names>Mousumi</given-names> <surname>Banerjee</surname></string-name>, <string-name><given-names>Veer-abhadran</given-names> <surname>Baladandayuthapani</surname></string-name>, <string-name><given-names>Parikshit</given-names> <surname>Ghosh</surname></string-name>, and <string-name><surname>Bhramar</surname> <given-names>Mukherjee.</given-names></string-name> <article-title>Predictions, Role of Interventions and Effects of a Historic National Lockdown in India&#x2019;s Response to the the COVID-19 Pandemic: Data Science Call to Arms</article-title>. <source>Harvard Data Science Review</source>, <month>June</month> <year>2020</year>. Publisher: PubPub.</mixed-citation></ref>
<ref id="c34"><label>[34]</label><mixed-citation publication-type="journal"><string-name><given-names>Ester C</given-names> <surname>Sabino</surname></string-name>, <string-name><given-names>Lewis F</given-names> <surname>Buss</surname></string-name>, <string-name><given-names>Maria PS</given-names> <surname>Carvalho</surname></string-name>, <string-name><given-names>Carlos A</given-names> <surname>Prete</surname></string-name>, <string-name><given-names>Myuki AE</given-names> <surname>Crispim</surname></string-name>, <string-name><given-names>Nelson A</given-names> <surname>Fraiji</surname></string-name>, <string-name><given-names>Rafael HM</given-names> <surname>Pereira</surname></string-name>, <string-name><given-names>Kris V</given-names> <surname>Parag</surname></string-name>, <string-name><given-names>Pedro da Silva</given-names> <surname>Peixoto</surname></string-name>, <string-name><given-names>Moritz UG</given-names> <surname>Kraemer</surname></string-name>, <etal>et al.</etal> <article-title>Resurgence of covid-19 in manaus, brazil, despite high seroprevalence</article-title>. <source>The Lancet</source>, <volume>397</volume>(<issue>10273</issue>):<fpage>452</fpage>&#x2013;<lpage>455</lpage>, <year>2021</year>.</mixed-citation></ref>
<ref id="c35"><label>[35]</label><mixed-citation publication-type="journal"><string-name><given-names>Peter X.</given-names> <surname>Song</surname></string-name>, <string-name><given-names>Lili</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Yiwang</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>Jie</given-names> <surname>He</surname></string-name>, <string-name><surname>Bin</surname> <given-names>Zhu</given-names></string-name>, <string-name><given-names>Fei</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Lu</given-names> <surname>Tang</surname></string-name>, and <string-name><given-names>Marisa</given-names> <surname>Eisenberg</surname></string-name>. <article-title>An epidemiological forecast model and software assessing interventions on COVID-19 epidemic in China</article-title>. <source>MedRxiv</source>, <year>2020</year>. Publisher: Cold Spring Harbor Laboratory Press.</mixed-citation></ref>
<ref id="c36"><label>[36]</label><mixed-citation publication-type="other"><collab>Statista</collab>. <source>South Africa: Average age of the population from 1950 to 2050</source>.</mixed-citation></ref>
<ref id="c37"><label>[37]</label><mixed-citation publication-type="journal"><string-name><given-names>Nancy</given-names> <surname>Stiegler</surname></string-name> and <string-name><given-names>Jean-Pierre</given-names> <surname>Bouchard</surname></string-name>. <article-title>South Africa: Challenges and successes of the COVID-19 lockdown</article-title>. <source>Ann Med Psychol (Paris)</source>, <volume>178</volume>(<issue>7</issue>):<fpage>695</fpage>&#x2013;<lpage>698</lpage>, <month>September</month> <year>2020</year>.</mixed-citation></ref>
<ref id="c38"><label>[38]</label><mixed-citation publication-type="other"><string-name><given-names>Wendy</given-names> <surname>Sykes</surname></string-name>, <string-name><given-names>Laurette</given-names> <surname>Mhlanga</surname></string-name>, <string-name><given-names>Ronel</given-names> <surname>Swanevelder</surname></string-name>, <string-name><given-names>Tanya Nadia</given-names> <surname>Glatt</surname></string-name>, <string-name><given-names>Eduard</given-names> <surname>Grebe</surname></string-name>, <string-name><given-names>Charl</given-names> <surname>Coleman</surname></string-name>, <string-name><given-names>Nadia</given-names> <surname>Pieterson</surname></string-name>, <string-name><given-names>Russell</given-names> <surname>Cable</surname></string-name>, <string-name><given-names>Alex</given-names> <surname>Welte</surname></string-name>, <string-name><given-names>Karin</given-names> <surname>van den Berg</surname></string-name>, <etal>et al.</etal> <source>Prevalence of anti-sars-cov-2 antibodies among blood donors in northern cape, kwazulu-natal, eastern cape, and free state provinces of south africa in january 2021</source>. <year>2021</year>.</mixed-citation></ref>
<ref id="c39"><label>[39]</label><mixed-citation publication-type="other"><collab>Johns Hopkins University</collab>. <source>COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE)</source>.</mixed-citation></ref>
<ref id="c40"><label>[40]</label><mixed-citation publication-type="journal"><string-name><given-names>Chaolong</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Li</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Xingjie</given-names> <surname>Hao</surname></string-name>, <string-name><given-names>Huan</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>Qi</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Jiao</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>Na</given-names> <surname>He</surname></string-name>, <string-name><given-names>Hongjie</given-names> <surname>Yu</surname></string-name>, <string-name><given-names>Xihong</given-names> <surname>Lin</surname></string-name>, and <string-name><given-names>An</given-names> <surname>Pan</surname></string-name>. <article-title>Evolving epidemiology and impact of non-pharmaceutical interventions on the outbreak of Coronavirus disease 2019 in Wuhan, China</article-title>. <source>MedRxiv</source>, <year>2020</year>. Publisher: Cold Spring Harbor Laboratory Press.</mixed-citation></ref>
<ref id="c41"><label>[41]</label><mixed-citation publication-type="journal"><string-name><given-names>Dawei</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Bo</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>Chang</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>Fangfang</given-names> <surname>Zhu</surname></string-name>, <string-name><given-names>Xing</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Jing</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Binbin</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Hui</given-names> <surname>Xiang</surname></string-name>, <string-name><given-names>Zhenshun</given-names> <surname>Cheng</surname></string-name>, and <string-name><given-names>Yong</given-names> <surname>Xiong</surname></string-name>. <article-title>Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus&#x2013;infected pneumonia in Wuhan, China</article-title>. <source>Jama</source>, <volume>323</volume>(<issue>11</issue>):<fpage>1061</fpage>&#x2013;<lpage>1069</lpage>, <year>2020</year>. ISBN: <isbn>0098-7484</isbn> Publisher: American Medical Association.</mixed-citation></ref>
<ref id="c42"><label>[42]</label><mixed-citation publication-type="journal"><string-name><given-names>Zebin</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>Xin</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Feng</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Gaofeng</given-names> <surname>Zhu</surname></string-name>, <string-name><given-names>Chunfeng</given-names> <surname>Ma</surname></string-name>, and <string-name><given-names>Liangxu</given-names> <surname>Wang</surname></string-name>. <article-title>Prediction of the COVID-19 spread in African countries and implications for prevention and control: A case study in South Africa, Egypt, Algeria, Nigeria, Senegal and Kenya</article-title>. <source>Science of The Total Environment</source>, <volume>729</volume>:<fpage>138959</fpage>, <month>August</month> <year>2020</year>.</mixed-citation></ref>
</ref-list>
</back>
</article>